This special new paperback edition of St. George and the Dragon commemorates the 25th Anniversary of the Caldecott Award-winning picture book. Hodges retells an exciting segment from Spenser's The Faerie Queene, in which the Red Cross Knight slays a dreadful dragon that has been terrorizing the countryside for years, bringing peace and joy back to the land. Featuring a fresh new cover design - with artwork that highlights the dragon adventure within - and distinctive embossed gold Caldecott Award sticker, this is the perfect way to introduce the classic tale to a whole new generation of readers.

In a recent study of 61 hospitals, it was found that they bought 21 different types of A4 paper, 652 different kinds of surgical gloves and 1751 different cannulas. Police forces could cut the cost of their uniforms by over 30 per cent if they all bought the same one. But they disagree on how many pockets they need. Having committed to buy two new aircraft carriers, the MOD realised it didn't have the funds to buy them. The delayed delivery cost an additional GBP1.6 billion. We've spent GBP500 million on an abandoned project to centralise 999 calls, GBP3.5 billion on privatising the Work Programme, GBP700 million on implementing Universal Credit (used by 18,000 people), GBP20 billion on medical negligence claims, GBP70 billion (and counting) dealing with nuclear waste at Sellafield, and countless millions on IT investments in the BBC, the Home Office, the NHS . . . Waste is everywhere. Fighting against this waste is the Public Accounts Committee, which oversees some GBP700 billion of public spending every year. As its chair from 2010-15, Margaret Hodge knows the excesses of government bodies better than anyone. Conversational, witty, engaging and packed with anecdotes and insights about the biggest political figures of our time, Called to Account shines a light on some of the most fascinating - and alarming - issues that face Britain today.

Retells the segment from Spenser's The Faerie Queene, in which George, the Red Cross Knight, slays the dreadful dragon that has been terrorizing the countryside for years and brings peace and joy to the land.

The full results of clinical trials are being routinely and legally withheld from doctors and researchers by the manufacturers of medicines. The ability of doctors, researchers and patients to make informed decisions about treatments is being undermined. Regulators and the industry have recently made proposals to open up access, but these do not cover the issue of access to the results of trials in the past which bear on the efficacy and safety of medicines in use today. Research suggests that the probability of completed trials being published is roughly 50 per cent. And trials which gave a favourable verdict are about twice as likely to be published as trials giving unfavourable results. The Department and MHRA must make sure, both prospectively and retrospectively, that clinical trials are registered and the full methods and results of all trials are available for independent wider scrutiny by doctors and researchers. There is also no routine sharing between NICE and the MHRA of information provided by manufacturers during the process of licensing medicines. There is still a lack of consensus over how well the antiviral medicine Tamiflu, stockpiled for use in an influenza pandemic, actually works. It is disturbing that regulators do not appear to have access to all the available information. Before spending money in future to maintain the stockpile the Department needs to review what level of coverage is appropriate. It should look at the level of stockpiling in other countries, bearing in mind that the patent for the medicine runs out in 2016.